AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05832762 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) + Best medical treatment (BMT)
Description: Endovascular treatment (EVT) in the experimental arm can be performed with any recanalization strategy based on the operator's choice, and anatomical and radiological situation: MT using aspiration or stent retriever, with or without stenting (CE-labelled) or angioplasty. In case of acute stenting, the use of antiplatelet drugs will be based on the operator's preference, anatomical situation, and risk of hemorrhage.~Best medical treatment (BMT) : Administration of drugs is at the treating physician's discretion (for example, intravenous fibrinolysis, anticoagulants, or antiplatelet agents) according to the local standards of care, but not intra-arterial therapies.
Study NCT05832762 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Best medical treatment (BMT)
Description: Administration of drugs is at the treating physician's discretion (for example, intravenous fibrinolysis, anticoagulants, or antiplatelet agents) according to the local standards of care, but not intra-arterial therapies.
Study NCT05122130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: The donor site will be dressed with melatonin loaded gelatin sponge
Study NCT05122130 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Carbopol
Description: The donor site will be dressed with carbopol loaded gelatin sponge (placebo).
Study NCT06382090 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laughter yoga
Description: This practice, which includes deep breathing exercises and laughter exercises, takes approximately 45 minutes. The sessions will be conducted by the principal investigator.
Study NCT05242887 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Delirium screening using 3D-CAM and UB-CAM
Description: Patients will be evaluated with 3D-CAM and UB-CAM by a trained examiner (geriatrician, resident or neuropsychologist). On the same day, they will be given a reference diagnosis of delirium based on DSM-V criteria by another trained examiner, blind to the results of the UB-CAM and 3D-CAM.
Study NCT04725682 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tacrolimus
Description: a single dose of 1 mg capsule per period
Study NCT05904301 — intervention group
Intervention type: OTHER
Intervention: Usual medical management of patients, additional blood and stool samples for biobanking
Description: For all systemic diseases the following data will be collected:~Clinical examination, Laboratory data, Current medications, Constitution of biobanking.~For each disease:~Pathology specific Activity score, Global subjective disease activity by patient and by physician.
Study NCT05184010 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ulnar nerve mini open release
Description: the ulnar nerve mini open release was performed before arthroscopic release for elbow
Study NCT05184010 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: without ulnar nerve mini open release
Description: arthroscopic release for elbow stiffness alone without ulnar nerve mini open release
Study NCT04687176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Arsenic Trioxide Formulation
Description: Patients will be recruited to oral arsenic trioxide, all-trans-retinoic acid, ascorbic acid (AAA) based-induction for 42 days. Daunorubicin or idarubicin will only be used during induction in patients \<65 with presenting white blood cell count (WBC) ≥ 10 x 10\^9/L. In patients not receiving daunorubicin, hydroxyurea if WBC ≥ 5 x 10\^9/L within the first 14 days of induction. A reassessment bone marrow aspirate will be performed on day 28 of induction for assessment of morphologic remission.~Four weeks after the completion of induction phase, all patients, regardless of initial WBC, will receive two cycles of chemotherapy-free AAA consolidation (14 days every 28 days).~Four weeks after completion of consolidation, all patients will receive 12 cycles of chemotherapy-free AAA maintenance (14 days every 8 week).
Study NCT04384367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg + Naproxen 550mg
Description: oral - single dose
Study NCT04384367 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Maxalt 10Mg Tablet
Description: oral - single dose
Study NCT04384367 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Flanax 550mg
Description: oral - single dose
Study NCT04384367 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: oral - single dose
Study NCT05279404 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: electroacupuncture
Description: Electroacupuncture at Neiguan and Jianshi acupoint
Study NCT05279404 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: electroacupuncture
Description: Electroacupuncture at Neiguan and Jianshi acupoint
Study NCT05214053 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cone Beam CT
Description: Each patient will undergo a Cone Beam CT and a MDCT
Study NCT04863521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MHP
Description: MyHealthyPregnancy app (MHP 3.0) is a mHealth app specifically focused on detection and referral for depression and IPV (Intimate Partner Violence) risk, in addition to its other pregnancy risk detection and support features.
Study NCT05710380 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Risk Map Decision Support System (DSS).
Description: The Risk Map DSS tool is an image analysis software that automatically interprets images of the prostate that were captured using an MR (magnetic resonance) scanner (an imaging technique that uses scanners to take pictures of the body). This tool can potentially identify additional areas of cancer in your prostate that may have otherwise been missed.
Study NCT05710380 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Description: A medical imaging test that uses a large machine/scanner to take images of the body and internal organs and structures.
Study NCT05710380 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI) Guided Biopsy
Description: A removal of tumor tissue from the body based on images of the prostate provided by a previous magnetic resonance imaging (MRI) test. Up to 2 biopsies on trial.
Study NCT05337904 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: On-Stimulation
Description: The surgical electrode implanted in target 1 (ACC) or target 2 (NAcc) by a pulse generating device is on.
Study NCT05337904 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Off-Stimulation
Description: The surgical electrode implanted in target 1 (ACC) or target 2 (NAcc) by a pulse generating device is off.
Study NCT06482242 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: My Best Alaska Life
Description: MBAL's combination of digital innovation, inclusive content, and youth-driven design positions it as a leading-edge intervention in the field of sexual health, with the potential to significantly impact the lives of Y/YA in AK and beyond. The open-access digital website enhances the reach and engagement of MBAL, particularly among adolescents who may prefer to seek information and support online in a private, self-paced setting. By allowing youth to fill out this tool at their own pace and return to their home page as they want to reflect/change answers, they can update it as their lives change. Additionally, MBAL incorporates interactive elements (question types of open response, ranking, scales, drag/drop; journaling prompts \& space) and personalized features (ex. avatars of common AK animals designed by Y/YA), allowing users to tailor their life planning experience according to their individual needs and preferences and return to their answers.
Study NCT06068400 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCMA/GPRC5D double CAR-T
Description: BCMA/GPRC5D double CAR-T is a new type CAR-T cells therapy for patients with Multiple Myeloma.
Study NCT06392126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nL-CHCHD-001
Description: Personalized antisense oligonucleotide
Study NCT06549634 — intervention group
Intervention type: DRUG
Intervention: Daratumumab
Description: Daratumumab is not being administered as part of the study. Patients will receive daratumumab as part of their clinical care, and blood and urine will be collected in order to measure biomarkers pre- and post-daratumumab administration
Study NCT05175625 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
Description: SARS-CoV-2 recombinant spike protein (25 µg) with Advax-SM adjuvant (15 mg); a single intramuscular injection into the deltoid muscle of the non-dominant arm
Study NCT06504745 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peer education
Description: experimental group
Study NCT06504745 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: control group
Description: instruction training
Study NCT05175625 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Saline placebo
Description: 0.9% sodium chloride (1 mL); a single intramuscular injection into the deltoid muscle of the non-dominant arm
Study NCT04571034 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Therapeutic Ultrasound
Description: A standard ultrasound machine (Vectratm by Chattanooga Group, Inc.) with inactive probe will be used to deliver sham massage.
Study NCT04571034 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Medium-Intensity Roller Massage
Description: This group will receive a single bout of roller massage at medium intensity (25 newtons of force directed perpendicular to the surface of the thigh).
Study NCT04571034 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High-Intensity Roller Massage
Description: This group will receive a single bout of roller massage at medium intensity (45 newtons of force directed perpendicular to the surface of the thigh).
Study NCT06478095 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visual aids
Description: Diagrams, models, and videos
Study NCT06602141 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Muscle Biopsy
Description: This procedure is used to sample muscle cells from the leg Vastus Lateralis (thigh) muscle.
Study NCT06602141 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Adipose Biopsy
Description: This procedure is used to sample fat tissue from the abdomen (belly).
Study NCT06602141 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Glucose Clamp
Description: In this test, we will measure the effect of insulin by giving you insulin and glucose (sugar) intravenously through an IV line in your arm.
Study NCT06602141 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Accelerometer
Description: The tri-axial accelerometer measure activity and uses those values to estimate the number of calories burned based on your height, weight, age, and gender. The monitor also evaluates physical effort and the body's response to different activities.
Study NCT06602141 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Endurance Exercise
Description: Visit the study site 3 times a week to engage in endurance exercise training for approximately 12 weeks. Each session will last approximately 75 minutes, and exercise group can choose to use either a stationary bike or a treadmill to complete the training.
Study NCT06602141 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity/ dietary habits
Description: Visit the study site bi-weekly to get weight measurements and speak to the study team about weight maintenance and participant physical activity/dietary habits.
Study NCT06602141 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Heavy Water Labeling Period
Description: Participants in both control groups will be required to drink heavy water, which is ordinary water that is enriched with deuterium (stable, non-radioactive isotope) and called deuterium-labeled water, for 12 weeks.
Study NCT05045183 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SoC Adhesive Bandage
Description: On the randomized wound site, a SoC adhesive bandage will be applied.
Study NCT05045183 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SoC Adhesive Bandage
Description: On the randomized wound site, a SoC adhesive bandage will be applied.
Study NCT05045183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antibiotic Ointment
Description: On the randomized wound site, a antibiotic ointment will be applied.
Study NCT05045183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antiseptic Wash
Description: On the randomized wound site, a antiseptic wash will be applied.
Study NCT05045183 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hydrocolloid Pad
Description: On the randomized wound site, hydrocolloid pad will be applied.
Study NCT05971420 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VR activity-based
Description: VR games activities were chosen for simulated cognitive-motor training in the VR group. The VR training modules for this study included fire drill, walking exercise, balancing game activities and community shopping practices. These training modules involved dual task components; the participant was expected to train up his/her physical and cognitive motor performances in an 8-week VR activity-based program. VR group participants received 2-sessions per week, 16 training sessions in total.
Study NCT05971420 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise-based (Baduanjin)
Description: The exercise group used a traditional Chinese Qigong Baduanjin exercise incorporating with a fall prevention education strategy.
Study NCT05066529 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: dry-needling
Description: Dry needling is a technique in which a fine needle is used to penetrate the skin, subcutaneous tissues and muscles to mechanically disrupt tissue without the use of anesthesia. Treatment is often used to treat myofascial trigger points.
Study NCT05066529 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: dry-needling
Description: Dry needling is a technique in which a fine needle is used to penetrate the skin, subcutaneous tissues and muscles to mechanically disrupt tissue without the use of anesthesia. Treatment is often used to treat myofascial trigger points.
Study NCT06657404 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: use Amiodarone, Bisoprolol and Digoxin
Description: Amiodarone 200mg tid orally for 1 week, then reduced to 200mg bid orally for another week.~The dose of amiodarone will be reduced to 200mg bid orally for 1 week, and then 200mg qd maintenance treatment will be started in the 3rd week of dosing.~Bisoprolol 2.5-5mg qd oral treatment, the specific dose is decided by the investigator.~Digoxin 0.125mg qd orally.
Study NCT06657404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: use Amiodarone, Bisoprolol and Digoxin
Description: Amiodarone 200mg tid orally for 1 week, then reduced to 200mg bid orally for another week.~The dose of amiodarone will be reduced to 200mg bid orally for 1 week, and then 200mg qd maintenance treatment will be started in the 3rd week of dosing.~Bisoprolol 2.5-5mg qd oral treatment, the specific dose is decided by the investigator.~Digoxin 0.125mg qd orally.
Study NCT06656676 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WePrEP: A shared decision-making tool
Description: WePrEP will be bilingual, both patient- and provider-facing, stored on the provider's electronic device (and will have the capability to integrate with electronic health records in the future to enable scalability), and easily accessible during in-person or virtual patient-provider encounters. WePrEP is designed to present pertinent PrEP information to transgender women and their PrEP service providers to stimulate discussions about PrEP choice and support adherence (once a PrEP strategy has been chosen). We hypothesize that this will ensure selection of the ideal PrEP method and improve subsequent adherence.
Study NCT06656676 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active comparator: CDC recommendations for discussing PrEP
Description: Standard of care recommendations to discuss PrEP with potential end-users, endorsed by the CDC.
Study NCT06656806 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Measure concentrations of CBD in spot urine collections from subjects treated with inhaled CBD
Description: Measure concentrations of CBD in spot urine collections from subjects with generalized anxiety disorder treated with inhaled CBD
Study NCT06656806 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Determine the presence and concentration of CBD in subject's plasma with inhaled CBD
Description: Determine the presence and concentration of CBD in plasma of subjects with generalized anxiety disorder treated with inhaled CBD
Study NCT05783973 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Next generation sequencing
Description: Extract DNA from bile，tissue and tissue sample, minimum DNA amount should be over 50ng.
Study NCT06656962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telitacicept 160mg
Description: Telitacicept for Injection combined with standard therapy (Prednisone and Cyclophosphamide) for the treatment of ANCA-associated nephritis (AAGN).
Study NCT06656962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone (and methylprednisolone)
Description: Methylprednisone shock therapy (500mg, 3 times), followed by Prednisone (1 mg·kg·d and a pre-determined tapering guideline \[PEXIVAS regimen\]).
Study NCT06656962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide, intravenous injection, once every 2 to 3 weeks, 0.75 g/m² each time, the maximum cumulative dose of 8g
Study NCT06656871 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: iron supplementation
Description: The iron tablet group received iron supplementation (30 mg, 1 tablet/day of iron) for 4 weeks
Study NCT06656871 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Biostimulated lettuce supplementation
Description: the intervention group SwE lettuce group received lettuce biostimulated with Ecklonia Maxima algae (SwE lettuce, 100 grams/day) daily for 4 weeks
Study NCT06656728 — intervention group
Intervention type: OTHER
Intervention: Blood-based liquid biopsy
Description: Venous blood sample will be taken from the patient as part of the routine blood tests taken as part of the work at the Medical Center
Study NCT06655922 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: FAPI Imaging
Description: Studies have shown that imaging with radionuclide-labeled fibroblast activation protein inhibitor (FAPI) is a reliable technique for detecting myocardial fibrosis and activated CFs in arteries. Preliminary evidence suggests that FAPI imaging can assess plaque characteristics and the status of myocardial fibrosis in various cardiovascular diseases.
Study NCT06657287 — intervention group
Intervention type: OTHER
Intervention: Mixed meal test
Description: The biochemical parameters, blood pressure, and heart rates of participants undergoing the mixed meal test will be recorded over a 5-hour period.
Study NCT06617481 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 18F-rhPSMA-7.3 (Posluma)
Description: PET Scan using Posluma for detection of early recurrence of prostate cancer.
Study NCT04714671 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The virtual version of the Social stress task : V-TSST
Description: The task consists in a brief presentation about the abilities of participants followed by an arithmetic task in front of a virtual 3D audience projected and one researcher in a small room.First, participants have 5 minutes to prepare an exhibition about their qualities, their strengths and defects, and, why they identify with them. During this period virtual reality shows a closed curtain, and sounds from the audience can be heard. In the second phase, the curtain is raised and the participant must expose his speech during 5 minutes. Audience will remain attentive during 2 minutes, then audience will change to a restless attitude. The third phase consists of subtracting back a two-digit number from a four-digit number, as quickly as possible, starting again if participant makes a mistake. A debriefing of the test is scheduled at the end of the protocol, to remind patients of the purely fictional nature of this test. The visit will only end after a return to the baseline emotional state
Study NCT05436249 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Neurofeedback treatment
Description: During the fMRI scan, the tasks consist of:~1. Overt finger tapping in time with a flashing cue.~2. Motor imagery (of finger tapping).~During overt finger tapping, feedback will consist of a slider bar that indicates tapping accuracy to target speed (1 or 4Hz). During motor imagery, neurofeedback will consist of a slider bar that indicates the success of recruiting predicted brain regions (consistent with those engaged during overt tapping).
Study NCT04866108 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fruquintinib plus capecitabine
Description: oral fruquintinib plus capecitabine
Study NCT04525092 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Online Pre-dilution Hemodiafiltration
Description: The following parameters: maximum Blood flow rate allowed by vascular access, dialyste rate of 500 mL/min and average convective volume of >44L/session reinjected in pre-dilution mode. The dialysate composition, net ultrafiltration rate and use of anticoagulation will be prescribed according to participant's characteristics.